Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass.


Roux-en-Y gastric bypass surgery (RYGBP) leads to improvements in satiety and obesity-related comorbidities. The mechanism(s) underlying these improvements are not known but may be revealed in part by discovery proteomics. Therefore, fasting plasma was collected from 12 subjects (mean BMI >45) during RYGBP and during a second procedure approximately 17… (More)
DOI: 10.1038/oby.2008.428